NEPA

DRUG3 trials

Sponsors

Chinese University of Hong Kong, Tianjin Medical University Cancer Institute and Hospital

Conditions

Breast CancerBreast Cancer Patients Treated With T-DXdGeneral Anesthesia Gastrointestinal Cancer Surgery

Phase 2

AKY15-HK-301_NEPA Study

Active, not recruitingNCT03386617

Chinese University of Hong KongBreast Cancer

Start: 2018-02-27End: 2028-12-31Updated: 2026-03-04

Phase 4

A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients

Not yet recruitingNCT07254416

Tianjin Medical University Cancer Institute and HospitalBreast Cancer Patients Treated With T-DXd

Start: 2025-12-15End: 2027-06-30Target: 120Updated: 2025-11-28

Unknown Phase

The Safety and Effectiveness of NEPA in Preventing Postoperative Nausea and Vomiting After General Anesthesia Gastrointestinal Cancer Surgery: A Single-Center Retrospective Study

RecruitingNCT06417567

Tianjin Medical University Cancer Institute and HospitalGeneral Anesthesia Gastrointestinal Cancer Surgery

Start: 2024-05-15End: 2026-12-31Target: 50Updated: 2024-05-16

Related Papers

NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin

BMJ Supportive & Palliative Care2020-01-2915 citations